Monday 12 October 2026 Export all AMGN data to Excel Powerpack

Amgen Inc.

AMGN Healthcare Drug Manufacturers General

Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.

414.87 7.43 +1.82%
Market cap
$224.3B
P/E
25.6×
Fwd P/E
22.7×
Dividend yield
2.40%
F-score
7/9
Altman Z
1.69
Beneish M
−2.27
Dividend safety
56/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

81.71% 106.10% 101.32% 91.47%
Piotroski F-Score
7 7 8 8
ROA
7.74% 8.45% 8.58% 9.53%
ROIC
9.90% 10.48% 12.12% 12.98%
Return on Tangible Assets
52.61% 67.16% 52.93% 48.56%
Average Days of Receivables
86.15 95.05 89.61 97.99
Free Cash Flow per Share
21.45 15.06 15.92 18.84
Free Cash Flow
11,539.00 8,100.00 8,597.00 10,175.00
Capital Expenditures
(1,587.00) (1,858.00) (2,159.00) (2,303.00)
Other line items
Cash ROIC
15.67% 11.19% 10.94% 12.26%
Accounts Receivable Turnover
4.55 4.50 4.31 4.03
Accounts Payable Turnover
4.88 5.63 4.42 3.95
Inventory Turnover
1.78 1.82 1.83 1.81
Average Days of Payables
85.10 71.77 90.69 90.05
Days of Inventory on Hand
190.28 188.76 191.14 195.50
Tax Rate
(0.15) (0.14) (0.14) (0.15)
Research and Development Expense of Revenue
19.05% 19.79% 20.16% 20.03%
Selling, General and Administrative Expense of Revenue
19.39% 19.18% 18.71% 18.42%
Share Based Compensation of Revenue
1.40% 1.34% 1.30% 1.29%
Interest Coverage
3.04 3.30 3.93 4.28
Operating CF/Net income
1.87 1.29 1.38 1.43
Depreciation/Fixed assets
0.92 0.80 0.64 0.59
Capex/Depreciation
(0.24) (0.29) (0.41) (0.45)
Revenue per Share
66.86 68.31 68.93 70.55
Operating CF per Share
24.40 18.51 19.92 23.11
Capex per Share
(2.95) (3.45) (4.00) (4.26)
Capex to Sales
0.04 0.05 0.06 0.06

Fold the line items

Columns are period end dates